12:00 AM
 | 
Jun 17, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Qsymia regulatory update

The American Association of Clinical Endocrinologists (AACE) recommended the use of obesity drugs, such as Belviq lorcaserin from Eisai Co. Ltd. (Tokyo:4523; Osaka:4523, Tokyo, Japan) and

Read the full 140 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >